Cantargia has commenced an expanded segment of the ongoing Phase I trial of its antibody, CAN10, with the first participant ...

Researchers report results of the first-in-human phase 1 clinical trials of a novel immunotherapy approach for solid tumors ...

Discover how nicotinamide riboside reduces airway inflammation in COPD patients by lowering IL-8 levels and enhancing ...

A new study has uncovered an unexpected way cancer cells can escape the immune system, making it harder for treatments to work. The study, published in Cancer Cell, explains how a type of cancer cell ...

A new study has uncovered an unexpected way cancer cells can escape the immune system, making it harder for treatments to ...

In a new study of mouse cells, scientists found that both the biochemical and mechanical effects of exercise may help injured ...

A new study has uncovered an unexpected way cancer cells can escape the immune system, making it harder for treatments to work. The study, published in Cancer Cell, explains how a type of cancer cell ...

IMUNON (IMNN) announced the outcome of its recent End-of-Phase 2 in-person meeting with the U.S. Food and Drug Administration, FDA, supporting ...

A new study has uncovered an unexpected way cancer cells can escape the immune system, making it harder for treatments to work. The study explains how a type of cancer cell death can actually make ...

According to the World Health Organization (WHO), cancer remains one of the leading causes of death globally, responsible for ...

Type 2 diabetes (T2D) and obesity (OB) are associated with chronic low-grade inflammation and increased fracture risk. In vitro studies showed that inflammation induces bone erosion and inhibits bone ...

In the trial, 20% of patients didn’t respond well to the PCSK9 inhibitor—could genetic markers be used to tailor therapy?